Literature DB >> 3667799

High-performance liquid chromatographic determination of amphotericin B in human serum.

C Brassinne1, C Laduron, A Coune, J P Sculier, C Hollaert, N Collette, F Meunier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3667799     DOI： 10.1016/0378-4347(87)80307-9

Source DB:  PubMed          Journal:  J Chromatogr


× No keyword cloud information.
  10 in total

1.  Distribution of lipid formulations of amphotericin B into bone marrow and fat tissue in rabbits.

Authors:  A H Groll; D Mickiene; S C Piscitelli; T J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

2.  Dosage-dependent antifungal efficacy of V-echinocandin (LY303366) against experimental fluconazole-resistant oropharyngeal and esophageal candidiasis.

Authors:  V Petraitis; R Petraitiene; A H Groll; T Sein; R L Schaufele; C A Lyman; A Francesconi; J Bacher; S C Piscitelli; T J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

3.  Mechanism of amphotericin B resistance in Leishmania donovani promastigotes.

Authors:  N Mbongo; P M Loiseau; M A Billion; M Robert-Gero
Journal:  Antimicrob Agents Chemother       Date:  1998-02       Impact factor: 5.191

4.  Successful treatment with liposomal amphotericin B in two patients with persisting fungemia.

Authors:  J P Sculier; D Bron; A Coune; F Meunier
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-10       Impact factor: 3.267

5.  Pharmacokinetics and safety of a unilamellar liposomal formulation of amphotericin B (AmBisome) in rabbits.

Authors:  J W Lee; M A Amantea; P A Francis; E E Navarro; J Bacher; P A Pizzo; T J Walsh
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

6.  Efficacy of PLD-118, a novel inhibitor of candida isoleucyl-tRNA synthetase, against experimental oropharyngeal and esophageal candidiasis caused by fluconazole-resistant C. albicans.

Authors:  Vidmantas Petraitis; Ruta Petraitiene; Amy M Kelaher; Alia A Sarafandi; Tin Sein; Diana Mickiene; John Bacher; Andreas H Groll; Thomas J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

7.  Flow cytometric assay for estimating fungicidal activity of amphotericin B in human serum.

Authors:  E Martin; U Schlasius; S Bhakdi
Journal:  Med Microbiol Immunol       Date:  1992       Impact factor: 3.402

8.  Measurement of the concentration of amphotericin B in brain tissue of scrapie-infected hamsters with a simple and sensitive method.

Authors:  P Casaccia; A Ladogana; Y G Xi; L Ingrosso; M Pocchiari; M C Silvestrini; A Cittadini
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

9.  Comparison of nephrotoxicities of different polyoxyethyleneglycol formulations of amphotericin B in rats.

Authors:  C Tasset; V Preat; A Bernard; M Roland
Journal:  Antimicrob Agents Chemother       Date:  1992-07       Impact factor: 5.191

10.  Tissue concentrations and bioactivity of amphotericin B in cancer patients treated with amphotericin B-deoxycholate.

Authors:  N Collette; P van der Auwera; A P Lopez; C Heymans; F Meunier
Journal:  Antimicrob Agents Chemother       Date:  1989-03       Impact factor: 5.191
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.